2011
DOI: 10.1200/jco.2011.29.15_suppl.tps249
|View full text |Cite
|
Sign up to set email alerts
|

ACRIN 6691 monitoring and predicting breast cancer neoadjuvant chemotherapy response using diffuse optical spectroscopic imaging (DOSI).

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2012
2012
2015
2015

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 0 publications
0
2
0
Order By: Relevance
“…34 A multicentre clinical trial on the efficacy of NIR monitoring of neoadjuvant chemotherapy is currently recruiting patient-volunteers. 137 In the phase I/II multicentre study at five clinical sites, women who have been diagnosed with breast cancer, who have had confirmation of disease by pre-treatment biopsy and are scheduled to receive neoadjuvant chemotherapy followed by surgery are eligible for the trial.…”
Section: Discussionmentioning
confidence: 99%
“…34 A multicentre clinical trial on the efficacy of NIR monitoring of neoadjuvant chemotherapy is currently recruiting patient-volunteers. 137 In the phase I/II multicentre study at five clinical sites, women who have been diagnosed with breast cancer, who have had confirmation of disease by pre-treatment biopsy and are scheduled to receive neoadjuvant chemotherapy followed by surgery are eligible for the trial.…”
Section: Discussionmentioning
confidence: 99%
“…Currently, no standardized modalities and timing for the assessment of an early pathologic response have been established. Optical techniques are showing good promise for monitoring the effectiveness of neoadjuvant chemotherapy and even predicting the therapeutic response [8][9][10] . Actually, it seems possible to predict the outcome of the neoadjuvant chemotherapy just after the first day of treatment, or even before the start, based on characteristic features of breast tissue that provide indication on its responsiveness to treatment [11][12][13] .…”
Section: Introduction To Time-resolved Diffuse Optical Spectroscopymentioning
confidence: 99%